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The N protein from bacteriophage  is a key regulator of transcrip-
tion antitermination. It specifically recognizes a nascent mRNA
stem loop termed boxB, enabling RNA polymerase to read through
downstream terminators processively. The stacking interaction
between Trp-18 of WT N protein and A7 of boxB RNA is crucial for
efficient antitermination. Here, we report on the direct probing of
the dynamics for this interfacial binding and the correlation of the
dynamics with biological functions. Specifically, we examined the
influence of structural changes in four peptides on the femtosec-
ond dynamics of boxB RNA (2-aminopurine labeled in different
positions), through mutations of critical residues of N peptide
(residues 1–22). We then compare their in vivo (Escherichia coli)
transcription antitermination activities with the dynamics. The
results demonstrate that the RNA–peptide complexes adopt es-
sentially two dynamical conformations with the time scale for
interfacial interaction in the two structures being vastly different,
1 ps for the stacked structure and nanosecond for the unstacked
one; only the weighted average of the two is detected in NMR by
nuclear Overhauser effect experiments. Strikingly, the amplitude
of the observed ultrafast dynamics depends on the identity of the
amino acid residues that are one helical turn away from Trp-18 in
the peptides and is correlated with the level of biological function
of their respective full-length proteins.
Macromolecular assemblies play critical roles in biologicalprocesses, such as expression (1), recognition (2, 3), and
catalysis (4, 5). In these assemblies, the interactions are selective
in forming unique structures with dynamics governing the
functions. One such complex is that of RNA with proteins. It
involves the bacteriophage  N protein, which binds a cis-acting
stem-loop RNA structure (termed boxB) in nascent mRNA
coded in the phage genome, and regulates transcription elon-
gation and termination (6–8). With other host protein factors,
the complex enables RNA polymerase to read through intrinsic
and Rho-dependent terminators in a processive manner (9).
NMR structural studies (10–12) demonstrated that the amino
terminal of the N protein (N peptide), which features an
arginine-rich motif, binds to the boxB RNA hairpin as a bent
-helix, and this process enforces the purine-rich boxB RNA
pentaloop to adopt a canonical GNRA fold (13, 14) with the
fourth purine residue extruded (Fig. 1). One unique interaction
featured in this RNA–peptide complex is that of the side chain
of the tryptophan residue (Trp-18), which directly stacks on
adenine 7, extending the RNA -stack by one residue (Fig. 1).
Different peptide ligands can target boxB RNA with strong
equilibrium affinities (nanomolar range for dissociation con-
stant) similar to the WT (15), as we have shown by in vitro protein
selection via mRNA display (16, 17). However, examination of
the energetics and structures by NMR, CD, and steady-state
fluorescence on some of the selected 1415 mutants (Fig. 1)
reveal that they have quite a different Trp-18RNA interface
from that of the WT complex. As discussed below, the degree of
stacking (Trp-18 on A7) decreases in the order of KQ (WT), KH,
KR, and ER. It is the structural changes (stacking) at the
Trp-18A7, rather than binding affinities, that give rise to a wide
range of in vivo antitermination activity, as elucidated below.
Questions remain, however, regarding the exact nature of the
different RNA–protein interfaces. It is also unclear how
the function is correlated with the dynamical time scales of the
structures involved, the intramolecular motions, and the inter-
action with the environment including water (18). Here, we use
the fluorescent analogue of adenine, 2-aminopurine (Ap), which
has been extensively used as a probe for nucleic acid conforma-
tional dynamics (19) and ultrafast electron transfer in DNA (20),
to directly examine the femtosecond dynamics of interfacial
charge transport between Ap at selected loop positions (by
designed replacements) and the tryptophan of the peptides and
the other nucleobases in the loop.
Experimental Procedures
Synthesis of RNAs and Peptides. The Ap-labeled RNAs were
generated by solid-phase synthesis via standard phosphoramidite
chemistry, deprotected, and purified by 20% urea-PAGE. Pep-
tides were made by automated fluorenylmethoxycarbonyl syn-
thesis (Applied Biosystems 432), deprotected, and purified by
reversed-phase HPLC on a C18 column. Concentrations of
RNAs and peptides were determined by UV absorbance at 260
and 280 nm, respectively. RNA (typically in 200 M) was
annealed in buffer of 50 mM NaCl10 mM phosphate, pH 6;
aliquot of concentrated peptide solutions was added to RNA to
form an RNA–peptide complex with a 1:1.5 ratio.
Time-Correlated Single-Photon Counting (TCSPC). The TCSPC mea-
surements were performed by using picosecond pulses from a
cavity-dumped dye (DCM) laser. Laser output was at 650 nm and
doubled to 325 nm for selective excitation of Ap. The instrument
response has a full width at half maximum of 120 ps. The
fluorescence at 370 nm was collected through a monochromator
and detected with a microchannel plate. The excitation light was
polarized vertically, and the emission was taken through a
polarizer set at magic angle.
Femtosecond Fluorescence Up-Conversion. Femtosecond fluores-
cence up-conversion procedures have been described, and we
used two laser systems (21, 22) for entirely independent sets of
experiments. Ap is excited by a pump pulse at 320 nm. The
energy of the excitation pulse was kept at 60 nJ, but care was
taken to ensure that the low-power regime is valid; at higher-
power densities, some artifact signals arise even from the pep-
tidebuffer alone. The emission was collected by a pair of
parabolic focus mirrors and mixed with the fundamental (800
nm) in the BBO crystal. The up-converted signal (257 or 260 nm)
was detected by a photomultiplier after passing through a
Abbreviations: Ap, aminopurine; TCSPC, time-correlated single-photon counting.
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double-grating monochromator. The pump beam polarization
was set at a magic angle with respect to fluorescence polarization
set by the BBO crystal. In all of the experiments, the temperature
of the sample quartz cell was controlled at 20°C or room
temperature, and the samples were stirred. All of the data were
fitted to multiexponential decay convoluted by a Gaussian
response function as described (21). Transient absorption data
have also been obtained and will be detailed elsewhere.
Transcription Antitermination Assay. N WT and mutant strains
were constructed by using the two-plasmid reporter system as
described (23). All sequences were verified by sequencing. N
mutant strains were plated on tryptone agar supplemented with
0.05 mM isopropyl--D-galactopyranoside, 0.08 mgml 5-bromo-
4-chloro-3-indolyl--D-galactopyranoside, and the appropriate
antibiotics. Plates were scored for blue color. A colorimetric
assay based on o-nitrophenyl--D-galactopyranoside was also
used to quantitate -galactosidase as a percentage of the WT N
reporter construct in the solution (24).
Results and Discussion
We prepared two sets of RNA–peptide complexes. The first set
is WT complexes (KQ) with the boxB RNA labeled at positions
7 (Ap-7), 8 (Ap-8), and 9 (Ap-9) individually (Fig. 1). Using
these complexes we can probe the different regions of the RNA
loop upon WT peptide binding. In the second set, we vary the
peptides, with KQ, KH, KR, and ER being the residues at
positions 14 and 15 (Fig. 1), all of which are complexed with
Ap-7 RNA so we can probe the peptide binding-dependent
dynamics at the RNA–peptide interface. We also used Esch-
erichia coli strains that harbor the two-plasmid N expressor
-galactosidase reporter system (23) to examine the transcrip-
tion antitermination activity for the respective full-length
protein mutants.
Dynamics of RNA–Peptide Complexes. All RNA–peptide complexes
studied here show drastic differences in their dynamics depend-
ing on the time scale. We first performed nanosecond time-scale
experiments on the series of Ap-7 complexes and the free Ap-7
RNA by using TCSPC techniques. As shown in Fig. 2, the
normalized fluorescence decay profiles for all of the systems
studied are very similar on the nanosecond time scale. Steady-
Fig. 1. Sequences and structures of boxB RNA, N peptide variants selected for
binding to boxB RNA (15), and their complexes used in this study. The WT
complex structure is taken from NMR (10, 11). The bases A7, A8, A9, and A10
are colored in red, green, blue, and yellow, respectively; RNA backbone and
other base pairs are in gray. The WT N peptide in the complex is represented
as red ribbon with side chains of Lys-14, Gln-15, and Trp-18 shown. Structure
of the boxB RNA pentaloop with U5-A11 closing base pair is viewed 90° from
the full complex; the stacking between Trp-18 and A7 is viewed from the top
of the loop.
Fig. 2. (Upper) TCSPC decay profiles for complexes of peptide variants with
Ap-7 boxB RNA. All TCSPC decay curves are normalized at time 0 and exhibit
multiple exponential nanosecond decay components. (Lower) Fluorescence
up-conversion traces for free Ap7 RNA, free WT peptide, and the complex
formed (Ap7-WT). The curves are not normalized. Note that the response of
the buffer solution or the free peptide shows no transient signal. The instru-
ment response measured by the Raman signal is shown for comparison.
8120  www.pnas.orgcgidoi10.1073pnas.1433099100 Xia et al.
state fluorescence measurements on these Ap-7 complexes show
large differences in their f luorescence intensities, and hence the
lack of large changes in the nanosecond decays for all complexes
suggests that the dynamics must occur on a much faster time
scale.
In Fig. 2, we show femtosecond-resolved transients by up-
conversion of Ap7 RNA in buffer, free peptide, buffer alone, and
the WT complex. Only the WT complex shows the ultrafast
decay (60%), elucidating the dynamics for RNA–protein in-
teractions. Accordingly, the multiple nanosecond decays ob-
served on a longer time scale represent the conformations that
do not undergo ultrafast decay, and their lifetimes are similar to
that of free Ap base. This finding indicates that in solution the
RNA–peptide complexes have conformations that feature an
unstructured loop, suggesting that the complexes sample other
conformational space and are not being localized in a narrow
well of a single native folded state. A similar phenomenon has
also been observed for Ap incorporated into some double-
stranded DNA constructs (20).
In Figs. 3 and 4, we report the primary dynamics for different
Ap positions of RNA complexed with WT peptide and for a
series of mutant complexes with different peptides. We first
examined the WT complex to monitor the decay behavior of
the Ap at the three different positions (at 7, 8, and 9) in the
RNA loop (Fig. 1). As shown in Fig. 3, Ap labels at loop
positions 7, 8, and 9 exhibit dramatically different decay
dynamics. At position 7, it shows an ultrafast (1 ps, 60%) decay
component, together with a 30-ps component (10%) and a
nanosecond component (30%). At position 8, the ultrafast
component (0.8 ps) is only 25%, with a 35-ps component
(40%) and a subnanosecond component (35%). By contrast,
position 9 shows essentially no ultrafast decay and only a
nanosecond component.
We then performed up-conversion experiments on the free
RNA and the mutant complexes. Fig. 4 shows the decay traces
for Ap-7 free RNA and complexes. Three decay components are
used in the global analysis: an ultrafast 1 ps, an intermediate
30 ps, and a nanosecond component. For the 1-ps decay
component, the WT has the largest (60%) and KH also has a
significant population (30%), whereas KR has a relatively small
(5%) and ER has near zero contribution. All complexes exhibit
low and similar levels of the intermediate 30-ps decay compo-
nent (5–10%, except 0% for ER). For the slow nanosecond
component, WT and KH have the smallest, yet still significant,
amplitude (30% and 60%), whereas it is dominant in both
KR (90%) and ER (100%) at a level similar to that in free
RNA (90%).
Fig. 3. Femtosecond fluorescence up-conversion decays measured for WT
peptide complexes with Ap-7, Ap-8, and Ap-9 boxB RNA and corresponding
steady-state fluorescence. (Inset) The expansion of the shorter time scale.
Steady-state fluorescence intensities are normalized to that of the Ap-9
complex.
Fig. 4. Femtosecond fluorescence up-conversion decays measured for vari-
ant complexes with Ap7 boxB RNA and the free RNA. (Upper) Decays were
collected to 300 ps, but are shown only to 60 ps. All of the traces were analyzed
individually and globally, and the results agree with each other within the
uncertainties of the measurements. (Lower) An independent set of experi-
ments showing the same dynamical behavior for complexes with Ap7 RNA,
measured for up to 10 ps.












Full Range of WT Complex Structures. These results elucidate the
nature of the dynamics at the RNA–peptide interface. First,
the results for the WT complex with Ap labeled at positions 7,
8, and 9 show the full range of different structures, those
‘‘oriented’’ for interfacial stacking and undergo ultrafast dy-
namics, and those ‘‘nonoriented’’ and whose decay is insignif-
icant on the femtosecond time scale. The rates ref lect the
change in stacking. In the WT complex, Trp-18 aromatic side
chain from the peptide, and the A7, A8 and A10 bases from the
RNA form continuous stacking steps, whereas A9 is extruded
(Fig. 1). This stacking pattern provides different electron
transfer pathways for Ap at different positions of the loop.
From the reduction potential of Ap* (estimated to be 1.5 V vs.
NHE) (25) and the oxidation potential of Trp (1.0 V vs. NHE)
(26, 27), we obtained the driving force G  0.5 V for the
electron transfer from Trp to Ap*. Compared with the driving
force for bases in DNA (28), the observed rates here are
consistent with the change in G and the stacking for different
positions of Ap.
Second, the up-conversion experiments on the WT com-
plexes reveal the existence of structures other than those
suggested by NMR. The NMR solution-phase structure of the
WT complex (10, 11) represents a weighted average by the
nuclear Overhauser effect detection method. The observed
ultrafast dynamics reported here distinguishes the different
conformations. The stacked structure is the one giving rise to
the ultrafast decay rates, and in fact the values of the rate
reported here (1 ps1 for the WT) indicate a very strong
effective interaction between Trp and A7. When comparing
with results obtained for Ap with guanine (20), the rate for the
WT complex is an order of magnitude larger, elucidating a
stronger effective stacking in the complex. The other non-
stacking structures are evident in our results of the magnitude
of the longtime nanosecond decay component, which is 30% in
the WT complex. These observations are consistent with the
notion that RNA–protein complexes are inherently dynamical;
a single static structure cannot accurately represent the inher-
ent heterogeneity of these macromolecular conformations. It
should be noted that the steady-state results (Fig. 3), although
consistent with the time-resolved data, do not provide the
behavior and rates discussed above.
Peptide Binding-Dependent Dynamics at RNAPeptide Interface. The
dynamics are critically altered depending on the nature of
the peptide interface to RNA. The questions of significance
are the following: which structures control the recognition of
RNA by the different peptides and what are the time scales
involved? And, given that we used a peptide library randomized
at positions 14 and 15 to select the peptides, is the recognition
of RNA by the peptides directed by the active binding site(s) of
RNA target, or is it controlled by other conformations? As
shown in Fig. 4, the observed ultrafast (1 ps) component is robust
for the entire series of complexes (KQ, KH, KR, and ER) but the
decrease in its magnitude follows the trend for stacking. The
results indicate that the mutant complexes have in common with
the WT complex a stacking structure (Fig. 1), and not new
conformations, with a population depending on the peptides.
This behavior was not evident in NMR observations of up-field
shift of Trp-18 indole NH proton (which is sensitive to ring
current of A7 underneath) and steady-state quenching results
(Fig. 4), which indicate a progressive unstacking of Trp-18 on A7
in the order of KQ, KH, KR, and ER. As will be detailed
elsewhere, the NMR shifts reflect an averaging, on the time scale
of the experiments, which may give the appearance of systematic
unstacking. We conclude that stacking structures are fundamen-
tal to all complexes and that the RNA target controls the
recognition modes, but this can be modulated by some residues
of the peptides.
Conclusions
The nature of the structures involved is depicted in Fig. 5. In a
two-state representation, we emphasize the stacked and un-
stacked complexes. The N-terminal portion (residues 1–11)
anchors the peptide on the RNA target (with M affinity; ref.
29), and the C-terminal portion (residues 12–22) may undergo
domain motion between a bend -helix that has Trp-18 stacking
at the interface with A7 of RNA and the unstacked complex,
where Trp-18 does not stack on A7. One of the unique features
of the charge transfer in these RNA–peptide complexes is that
the transfer proceeds across the interface between the two
biomolecules, RNA, and peptide, and is mediated through a
single-stranded stacking structure. Accordingly, the present
study expands the repertoire of constructs that we can probe for
these interfacial dynamics with femtosecond resolution. As
shown above, this is particularly useful for complicated biological
assemblies such as the complexes studied here.
The final conclusion from these results concerns the correla-
tion between the reported dynamics and the transcription anti-
termination activity for the respective full-length proteins mea-
sured in vivo (displayed in Fig. 5). The KH and KR have
WT-level activity, but ER has 10% of WT activity. In Fig. 5,
we show the biological in vivo activity and the amplitude of the
ultrafast component for WT, KH, and ER. The stacking of
Fig. 5. Two-state model of conformational equilibrium distribution in the
RNA–peptide complexes and comparison of the amplitude of the ultrafast
dynamic component with the level of in vivo (E. coli) antitermination activity.
(Upper) Stacked structure is a schematic representation of the WT complex
from NMR studies (10, 11). Domain motion of the C-terminal portion of N
peptides switches the stacked structure to the unstacked structure. The latter
can undergo further RNA conformational dynamics with an ensemble of
structures. (Lower) The KH and KR proteins have full activity when compared
with WT, and all three form the biological activity band indicated. In contrast,
the level of activity for the ER protein is10% of that of WT. The vertical line
is drawn to highlight a possible onset (see text) for the change in the ampli-
tude of the ultrafast dynamic component, which reflects the fraction of folded
(stacked) structures. The affinities (Kd) of peptides to boxB RNA measured in
vitro are shown for each complex.
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Trp-18A7 is a required element to maintain the proper assem-
bly of functional antitermination complex with other protein
factors. The relative population of the stacked structure is
reflected in a threshold-type behavior. Clearly, correlations of
structures and dynamics to functions, as we did here, is the key
for elucidating the molecular description of these biological
processes.
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